If you would like to submit a blog post for consideration, please email email@example.com
In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the three possible outcomes that can be reached after you check a lesion: Excise, monitor, or do nothing. In most cases, lesions are either deemed suspicious and excised, or deemed safe and the patient goes home. Giuseppe warns that the other option – monitoring the lesion at follow-up appointments – should be used with caution and in limited cases. He goes through the scenarios in which monitoring the lesion is a good choice and how doctors can go about the follow-up procedure. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2020]”
Sun damage is a common skin concern seen in primary care – from sunburns to pigmentation, sun spots, wrinkles and skin cancers. Research Review‘s latest educational series focuses on sunscreen and photoageing, with expert commentary by dermatologists. It explores the mechanisms of skin photoageing and the role of sunscreen as an adjunctive sun protection measure in the prevention of photoaeging. Continue reading “[2 min read] How does sunscreen prevent photoageing?”
Is psoriasis or psoriatic arthritis associated with an increased risk of cancer? A recent review looked at the association and risk of cancer in patients with these conditions. Continue reading “[2 min read] Is psoriasis associated with increased risk of skin cancer?”
Non-melanoma skin cancer is the most commonly diagnosed cancer in Australia, with around 800,000 confirmed cases each year. General practitioners alone have over one million skin cancer-related consultations annually, with lesion diagnosis being among patients’ most common skin concerns in primary care.
The two main types of non-melanoma skin cancer are: Continue reading “[3 min read] 5 common treatments for non-melanoma skin cancer”
In this month’s skin cancer update video, Professor Giuseppe Argenziano explores concepts around congenital naevi, in the last of a two-part series. He discusses how, if there is any precursor to melanoma, congenital naevi is the most important one.
In this month’s skin cancer update video, Professor Giuseppe Argenziano explores concepts around congenital naevi, in the first of a two-part series. He discusses the development of congenital naevi at birth and in the first decade of life, and their spontaneous involution or persistence throughout a patient’s lifetime.
In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses an interesting case from his own practice of a woman with a worsening, difficult-to-diagnose skin and hair condition on her scalp, which was finally diagnosed using dermoscopy. Continue reading “[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [April 2020]”
In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the criteria for sentinel node biopsies in melanoma patients. Using real patient case examples, he gives practical advice for how best to assess these patients to optimise their outcomes while avoiding unnecessary procedures. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [March 2020]”
Two treatments for advanced melanoma have had their PBS listings adjusted to include more patients. Continue reading “[2 min read] Two melanoma treatments added to the PBS”
New research suggests that the success of immunotherapy for melanoma can be predicted before treatment begins. A common issue with immunotherapies is that a drug that works well in many patients may have little effect in other patients with the same cancer type. But researchers have now identified new markers that can help predict which patients will have a better chance of responding positively to immunotherapy treatments. Continue reading “[6 min read] Can we predict melanoma immunotherapy success?”